Progress in Medicinal Chemistry: Progress in Medicinal Chemistry, cartea 56
David R. Witty, Brian Coxen Limba Engleză Hardback – 19 mar 2017
Users will find a comprehensive resource on the topic of medicinal chemistry that also discusses avenues for the acceleration of drug discovery programs.
- Extended, timely reviews of topics in medicinal chemistry
- Contains targets and technologies relevant to the discovery of tomorrow’s drugs
- Presents analyses of successful drug discovery programs
Toate formatele și edițiile | Preț | Express |
---|---|---|
Hardback (6) | 802.02 lei 5-7 săpt. | |
ELSEVIER SCIENCE – 17 mar 2019 | 802.02 lei 5-7 săpt. | |
ELSEVIER SCIENCE – 16 iun 2022 | 802.73 lei 5-7 săpt. | |
ELSEVIER SCIENCE – 4 mai 2020 | 803.58 lei 5-7 săpt. | |
ELSEVIER SCIENCE – 16 iun 2021 | 808.38 lei 5-7 săpt. | |
ELSEVIER SCIENCE – 19 mar 2017 | 837.20 lei 5-7 săpt. | |
ELSEVIER SCIENCE – 9 apr 2018 | 841.68 lei 5-7 săpt. |
Preț: 837.20 lei
Preț vechi: 1188.23 lei
-30% Nou
Puncte Express: 1256
Preț estimativ în valută:
160.22€ • 168.54$ • 133.69£
160.22€ • 168.54$ • 133.69£
Carte tipărită la comandă
Livrare economică 02-16 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780444639394
ISBN-10: 044463939X
Pagini: 174
Dimensiuni: 152 x 229 mm
Greutate: 0.43 kg
Editura: ELSEVIER SCIENCE
Seria Progress in Medicinal Chemistry
ISBN-10: 044463939X
Pagini: 174
Dimensiuni: 152 x 229 mm
Greutate: 0.43 kg
Editura: ELSEVIER SCIENCE
Seria Progress in Medicinal Chemistry
Public țintă
Everyone interested in the strategy and practice of the preclinical phases of the creation of new medicines. Those wishing to understand the drivers of drug design or expand their knowledge of therapeutic target classesCuprins
1. Enabling Chemistry Technologies and Parallel Synthesis—Accelerators of Drug Discovery ProgramsS.W. Djuric, A.R. Bogdan, H.F. Koolman, Y. Wang and A. Vasudevan2. Development of LRRK2 Inhibitors for the Treatment of Parkinson’s DiseaseK.V. Christensen, G.P. Smith and D.S. Williamson3. Recent Progress in the Discovery and Development of TRPA1 ModulatorsS. Skerratt4. Small Molecule Inhibition of Interleukin–1 Receptor-Associated Kinase 4 (IRAK4)N.E. Genung and K. Guckian